Nuvation Bio, Inc. (NUVB)
8.96
+0.02
(+0.22%)
USD |
NYSE |
Dec 31, 16:00
8.96
0.00 (0.00%)
After-Hours: 20:00
Nuvation Bio Profit Margin (Quarterly): -425.2% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Indivior PLC | 13.38% |
| Terns Pharmaceuticals, Inc. | -- |
| GRAIL, Inc. | -245.8% |
| Arrowhead Pharmaceuticals, Inc. | 6.29% |
| Nektar Therapeutics | -301.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -52.16% |
| Return on Assets | -38.11% |
| Return on Invested Capital | -43.02% |
| Gross Profit Margin (Quarterly) | 70.40% |
| Operating Margin (Quarterly) | -430.1% |
| Return on Net Operating Assets | -1.03K% |